Maxis Clinical Sciences


Maxis Clinical Sciences is a global research competence center and management consulting organization in the pharmaceuticals and life sciences sector, dedicated to patient-centric and outcome-driven clinical and drug development. They provide innovative solutions, strategic advisory, and comprehensive services including clinical trial management, real-world evidence solutions, digital health, AI integration, and more, with a focus on improving patient outcomes and healthcare delivery. The company actively incorporates emerging trends such as AI, real-world evidence, and digital health technologies to enhance clinical research and healthcare solutions.

Industries

artificial-intelligence
biopharma
biotechnology
clinical-trials
health-care
health-diagnostics
life-science
management-consulting
medical-device
pharmaceutical

Nr. of Employees

medium (51-250)

Maxis Clinical Sciences

Edison, New Jersey, United States, North America


Products

Clinical Function as a Service

Packaged offering that integrates clinical functions and FSP delivery models to support trial operations and analytics under flexible engagement arrangements.

Modular digital health platform

Modular platform components for patient-reported outcomes, site portals, telemedicine workflows and remote monitoring used to support decentralized and hybrid trials.

Tech-enabled FSP solutions

Integration of technology and intelligent workflows into FSP delivery models to accelerate study execution, enable analytics-driven operations and support tech-enabled resourcing models.


Services

Scalable delivery of clinical functional services — data management, biostatistics, statistical programming, clinical operations, medical writing, pharmacovigilance and quality/compliance — under multiple engagement models.

End-to-end RWD ingestion, curation, common-data-model mapping, analytics and RWE generation to create interoperable, regulatory-grade datasets for decision-making and HEOR.

Clinical data management, CDISC compliance, biostatistics, statistical programming and study data conformance to support trial reporting and regulatory submissions.

Development and deployment of patient- and site-facing digital platforms including ePRO/eCOA, portals, telemedicine workflows, remote monitoring and device integration to support decentralized and hybrid trials.

Regulatory strategy, SaMD classification and risk analysis, clinical evaluation and usability studies, quality management system implementation, software validation and premarket submission support.

Services for generating synthetic medical datasets, privacy-compliant tokenization and secure linkage of clinical trial and RWD sources to enable integrated analyses while protecting patient identity.

View All Services

Expertise Areas

  • Functional service provider (FSP) management
  • Real-world evidence generation and analytics
  • Clinical trial design and execution
  • Digital health and decentralized trials
  • Show More (10)

Key Technologies

  • OMOP Common Data Model (CDM)
  • Electronic data capture (EDC) systems
  • ePRO / eCOA platforms
  • AI / Machine Learning for clinical analytics
  • Show More (10)

News & Updates

Event highlighting the latest trends and insights in health economics and outcomes research, including the role of AI, real-world evidence, and holistic patient care.

Major event in the clinical research industry.

An article explaining the OMOP Common Data Model and its application in healthcare data standardization.

An overview of Functional Service Provider models in clinical research, emphasizing efficiency and cost-effectiveness.

An analysis of common causes of budget overruns in clinical trials and how FSP models can mitigate them.

30+ years of domain experience

Maxis Clinical Sciences has over 30 years of experience in healthcare and clinical research.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.